NASDAQ:NRC National Research (NRC) Stock Price, News & Analysis $19.08 +0.04 (+0.21%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$19.12 +0.04 (+0.21%) As of 05/22/2026 04:19 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About National Research Stock (NASDAQ:NRC) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get National Research alerts:Sign Up Key Stats Today's Range$18.78▼$19.2150-Day Range$16.46▼$19.2652-Week Range$11.01▼$22.79Volume115,758 shsAverage Volume113,214 shsMarket Capitalization$433.99 millionP/E Ratio48.92Dividend Yield3.35%Price TargetN/AConsensus RatingSell Company Overview National Research Corp (NASDAQ: NRC), also known as NRC Health, is a healthcare analytics and performance improvement company specializing in patient and employee experience measurement. The company’s cloud-based platform enables healthcare providers to collect real-time feedback through patient satisfaction surveys, post-discharge outreach, and employee engagement tools. NRC Health integrates clinical, operational and financial data to deliver actionable insights that support quality improvement initiatives and value-based care programs. Since its founding in the early 1990s and headquartered in Lincoln, Nebraska, National Research has expanded beyond its regional roots to serve more than 1,600 hospitals and 12,000 care sites across the United States and Canada. The company has evolved from traditional survey services to a comprehensive suite of analytics solutions, including market performance benchmarking, predictive modeling and customized reporting dashboards. Key products and services include patient experience measurement solutions that track and benchmark patient perceptions, employee engagement surveys designed to identify workforce trends, and post-discharge outreach that aids in care coordination and readmission reduction. NRC Health also offers advisory services to help healthcare organizations interpret data, implement best practices and monitor the impact of improvement efforts. National Research is overseen by a board of directors and managed by a team of senior executives with extensive backgrounds in healthcare quality, data science and information technology. The company maintains strategic partnerships with provider associations and research institutions to advance the use of patient-reported outcomes and analytics-driven decision-making in the healthcare industry.AI Generated. May Contain Errors. Read More National Research Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks3rd Percentile Overall ScoreNRC MarketRank™: National Research scored higher than 3% of companies evaluated by MarketBeat, and ranked 289th out of 297 stocks in the business services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingNational Research has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageNational Research has only been the subject of 1 research reports in the past 90 days.Read more about National Research's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of National Research is 48.92, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 38.98.Price to Earnings Ratio vs. SectorThe P/E ratio of National Research is 48.92, which means that it is trading at a more expensive P/E ratio than the Business Services sector average P/E ratio of about 30.50.Price to Book Value per Share RatioNational Research has a P/B Ratio of 32.34. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about National Research's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted1.98% of the float of National Research has been sold short.Short Interest Ratio / Days to CoverNational Research has a short interest ratio ("days to cover") of 5.5.Change versus previous monthShort interest in National Research has recently increased by 4.17%, indicating that investor sentiment is decreasing. Dividend0.8 / 5Dividend StrengthWeak Dividend YieldNational Research pays a meaningful dividend of 3.36%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthNational Research does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of National Research is 164.10%. Payout ratios above 75% are not desirable because they may not be sustainable.Read more about National Research's dividend. News and Social Media0.0 / 5News SentimentN/A News Coverage This WeekMarketBeat has tracked 1 news article for National Research this week, compared to 1 article on an average week.Search InterestOnly 1 people have searched for NRC on MarketBeat in the last 30 days. This is a decrease of -75% compared to the previous 30 days. Company Ownership0.9 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, National Research insiders have not sold or bought any company stock.Percentage Held by Insiders9.20% of the stock of National Research is held by insiders.Percentage Held by Institutions47.26% of the stock of National Research is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about National Research's insider trading history. Receive NRC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for National Research and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NRC Stock News HeadlinesNational Research (NASDAQ:NRC) Stock Passes Above 200 Day Moving Average - Here's WhyMay 22 at 4:09 AM | americanbankingnews.comNational Research (NASDAQ:NRC) Share Price Passes Above 200-Day Moving Average - Should You Sell?May 14, 2026 | americanbankingnews.comYour book attachedYour Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners guide...please take a few seconds and download it right now before your download link expires. That way, no matter what it costs in the future, you'll have a free copy on your computer.May 23 at 1:00 AM | Profits Run (Ad)NRC Health (NRC) Q1 2026 Earnings Call TranscriptApril 29, 2026 | seekingalpha.comNational Research NRC Q4 2025 Earnings TranscriptApril 22, 2026 | fool.comNRC Health Adopts New Name and Governance StructureApril 20, 2026 | tipranks.comNational Research CorporationApril 1, 2026 | edition.cnn.comPiedmont Names NRC Health as a Strategic Experience Partner to Support Mission-Driven GrowthMarch 19, 2026 | businesswire.comSee More Headlines NRC Stock Analysis - Frequently Asked Questions How have NRC shares performed this year? National Research's stock was trading at $18.77 at the start of the year. Since then, NRC stock has increased by 1.7% and is now trading at $19.08. How were National Research's earnings last quarter? National Research Corporation (NASDAQ:NRC) released its quarterly earnings results on Tuesday, April, 28th. The company reported $0.21 earnings per share (EPS) for the quarter. The company had revenue of $34.80 million for the quarter. National Research had a net margin of 6.52% and a trailing twelve-month return on equity of 122.73%. Read the conference call transcript. Does National Research have any subsidiaries? The following companies are subsidiaries of National Research: PatientWisdom Inc., The Governance Institute, and National Research Corporation Canada. Who are National Research's major shareholders? Top institutional shareholders of National Research include Dimensional Fund Advisors LP (2.15%), Renaissance Technologies LLC (1.50%), Bank of New York Mellon Corp (1.10%) and Heartland Advisors Inc. (1.04%). Insiders that own company stock include Amandla Mk Trust, Patrick E Beans and Jordan Nicole Freeman. View institutional ownership trends. How do I buy shares of National Research? Shares of NRC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of National Research own? Based on aggregate information from My MarketBeat watchlists, some other companies that National Research investors own include Meta Platforms (META), NVIDIA (NVDA), Tesla (TSLA), Alphabet (GOOG), Netflix (NFLX), Advanced Micro Devices (AMD) and JPMorgan Chase & Co. (JPM). Company Calendar Record date for 4/10 Dividend3/27/2026Ex-Dividend for 4/10 Dividend3/27/2026Dividend Payable4/10/2026Last Earnings4/28/2026Today5/23/2026Status update5/27/2026Record date for 7/10 Dividend6/26/2026Ex-Dividend for 7/10 Dividend6/26/2026Dividend Payable7/10/2026Next Earnings (Estimated)7/27/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (2m+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 NRC's financial health is in the Green zone, according to TradeSmith. NRC has been in this zone for over 2 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorBusiness Services Industry BUSINESS INFO SVC Sub-IndustryBusiness Services Current SymbolNASDAQ:NRC CIK70487 Webwww.nrchealth.com Phone(402) 475-2525Fax402-475-9061Employees490Year Founded1981Profitability EPS (Trailing Twelve Months)$0.39 Trailing P/E Ratio48.92 Forward P/E RatioN/A P/E GrowthN/ANet Income$11.60 million Net Margins6.52% Pretax Margin10.46% Return on Equity122.73% Return on Assets14.18% Debt Debt-to-Equity Ratio5.48 Current Ratio0.52 Quick Ratio0.52 Sales & Book Value Annual Sales$138.64 million Price / Sales3.13 Cash Flow$1.26 per share Price / Cash Flow15.14 Book Value$0.59 per share Price / Book32.34Miscellaneous Outstanding Shares22,746,000Free Float20,653,000Market Cap$433.99 million OptionableOptionable Beta0.31 Social Links Beginner's Guide To Retirement StocksClick the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report This page (NASDAQ:NRC) was last updated on 5/23/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredThe AI stocks about to become worthless (and one that isn't)Louis Navellier - who manages $1.1 billion including $358 million in AI stocks - says a new AI computer being ...InvestorPlace | SponsoredSpaceX just filed. The clock is ticking.Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding National Research Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share National Research With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
